The use of asthma medications by women of childbearing age is common. Exposure to pharmaceuticals during pregnancy may occur inadvertently or may be occasioned by therapeutic necessity. Although some information is known about the effects of asthma medications during pregnancy, there is still a significant amount of information to learn. Services of the Organization of Teratology Information Specialists are working together in the Asthma Medications in Pregnancy Project to gain additional information regarding the use of asthma medications during pregnancy as well as the impact asthma has on a pregnancy.

The Asthma Medications and Pregnancy Project is no longer enrolling new participants. If you are a current participant and have a question or comment, please call the participating Teratology Information Service (TIS) nearest to you [find a TIS] or call:

(866) 626-OTIS
(866) 626-6847

 

Recent results of the Asthma Medications and Pregnancy Project:

Bakhireva LN, Jones KL, Schatz M, Johnson D, Chambers CD, and the Organization of Teratology Information Services Research Group. "Asthma Medication Use in Pregnancy and Fetal Growth." J. Allergy Clin Immunol, 116:3, 503-9. [abstract]

"Asthma severity and pregnancy outcome" abstract of platform presentation at 42^nd Annual Conference of the Teratology Society, Teratology, 65(6) (2002). [pdf]

"Salmeterol Use and Pregnancy Outcome: A Prospective Multi-Center Study" Journal of Allergy and Clinical Immunology, 109(1)part 2 (2002). [pdf]

(To view/print pdf format, you need Acrobat Reader.)

 

Research Study Sponsor:
Sanofi-aventis

 

All information collected will remain strictly confidential. Identity of the women and their children will not be used in any report or publication and all files are kept in a locked cabinet. 

The coordinating center for the research study is located at the University of California, San Diego Medical Center in the Department of Pediatrics. The medical director is Dr. Kenneth Lyons Jones, a pediatrician and specialist in birth defects.

*OTIS is a national organization committed to research and the education of pregnant women and health care professionals about exposures during pregnancy.

 

rev. 3-February-2006